Vaccination of dogs

Last updated
Dog vaccination against rabies US Navy 070810-N-4954I-038 Lt. Col. Raveesh Chhajed, a veterinarian from the Indian Army, gives a rabies vaccination to a family dog during a veterinarian civil-assistance program.jpg
Dog vaccination against rabies

Vaccination of dogs is the practice of animal vaccination applied to dogs. Programs in this field have contributed both to the health of dogs and to the public health. In countries where routine rabies vaccination of dogs is practiced, for example, rabies in humans is reduced to a very rare event.

Contents

Currently, there are geographically defined core vaccines and individually chosen non-core vaccine recommendations for dogs. A number of controversies surrounding adverse reactions to vaccines have resulted in authoritative bodies revising their guidelines as to the type, frequency, and methods/locations for dog vaccination.

In 2010 [1] and 2011, [2] revised guidelines addressed concerns about adverse vaccine reactions [3] by altering the recommended frequency, type, methods, and locations for administration of core and non-core canine vaccines.

General schedule

Most vaccination protocols recommend a series of vaccines for puppies, with vaccine boosters given at 11-13 weeks, then at 15-17 weeks and so on. Frequency of vaccination thereafter varies depending on the lifestyle of the individual dog, including: [4]

Because these factors may change over time, many professional organizations [4] [5] recommend routine annual examinations, where a vaccination plan for each individual canine can be decided during a discussion between the veterinarian and dog owner.

Type

In their 2010 recommendations, WSAVA (World Small Animal Veterinary Association) [1] emphasized the importance of administering non-adjuvanted vaccines whenever possible, as vaccines that included these immune-stimulating agents were shown to increase adverse vaccine reactions in pets.

Frequency

WSAVA [1] also prefers serological testing over unnecessary boosters or re-vaccination doses of core vaccines after the initial 12-month booster that follows the puppy series of modified live virus [MLV] vaccines. This is because core vaccines show an excellent correlation between the presence of antibody and protective immunity to a disease, and have a long DOI (Duration of Immunity). Antibody tests can be used to demonstrate the DOI after vaccination with core vaccines, though not for non-core vaccines (such as parainfluenza).

Method

Most vaccines are given by subcutaneous (under the skin) or intramuscular (into the muscle) injection. Respiratory tract disease vaccination may be given intra-nasally (in the nose) in some cases.

Location

Many recent protocols indicate that vaccines should be given in specific areas in order to ease identification of which vaccine caused an adverse reaction and ease removal of any vaccine-associated sarcoma. [6] Although these protocols were initially designed for cats, some similar protocols are likely to be developed for canines, as well.

In North America, veterinarians adopted the practice of injecting specific limbs as far from the trunk of the body as possible, [7] for example the rear right limb for rabies.

This set of locations was not widely adopted outside of North America, and the international Vaccination Guidelines Group (VGG) made new recommendations [1] that vaccines be administered:

Core vaccines

Dog vaccination against canine distemper Bundesarchiv Bild 183-2005-0624-513, Berlin, Staupeimpfung fur Hunde.jpg
Dog vaccination against canine distemper

Core vaccines are defined as those vaccines which all dogs, regardless of circumstances, should receive. Core vaccines protect animals from severe, life-threatening diseases which have global distribution. [1]

Rabies

The 2011 North American recommendation [2] includes rabies in the core vaccines. Likewise, the National Association of State Public Health Veterinarians (NASPHV) in the U.S. gives detailed instructions on how to deal with what they describe as a serious public health problem, and includes a useful table, [8] summarizing all the rabies vaccines sold in the U.S.

The 2010 international VGG recommendation [1] generally considers the rabies vaccine a non-core vaccine, except in areas where the disease is endemic or where required by law.

CDV/CAV-2/CPV-2

In many locations the rabies vaccine is accompanied by a single combined vaccine shot which protects against:

This combination vaccine may also be known as DHPP or DAPP.

Non-Core vaccines

Non-core vaccines are those that are required by only those animals whose geographical location, local environment or lifestyle places them at risk of contracting specific infections. [1]

Generally not recommended, owing to unproven efficacy, are vaccines for:

Controversy

Specific adverse reactions and general consequences for long-term health and immunity are both being cited as reasons to reduce the frequency of pet vaccination.

The 2010 vaccination guidelines [1] published by the WSAVA (World Small Animal Veterinary Association) reduce the number of vaccines which should be considered core for canines, as well as recommending less frequent vaccine administration.

In the executive summary section, the WSAVA guidelines [1] argue in support of "the development and use of simple in-practice tests for determination of seroconversion (antibody) following vaccination." They also note that "Vaccines should not be given needlessly. Core vaccines should not be given any more frequently than every three years after the 12 month booster injection following the puppy/kitten series, because the duration of immunity (DOI) is many years and may be up to the lifetime of the pet." The open letter critique focuses on the less-nuanced summary of these recommendations in the tables given for vaccination guidelines, which could imply that re-vaccination should occur every three years.

Adverse reactions

Vets and owners should also consider factors that have been shown to increase the risk of adverse vaccine reactions. [3] Examples of such factors include:

Vaccine-induced vasculitis is a form of alopecia that occurs after vaccination, often due to rabies vaccination. It may occur 2-3 months after vaccination. [10]

See also

Related Research Articles

<span class="mw-page-title-main">Canine distemper</span> Viral disease affecting some mammals

Canine distemper virus (CDV) is a viral disease that affects a wide variety of mammal families, including domestic and wild species of dogs, coyotes, foxes, pandas, wolves, ferrets, skunks, raccoons, and felines, as well as pinnipeds, some primates, and a variety of other species. CDV does not affect humans.

<i>Bordetella</i> Genus of bacteria

Bordetella is a genus of small, Gram-negative, coccobacilli bacteria of the phylum Pseudomonadota. Bordetella species, with the exception of B. petrii, are obligate aerobes, as well as highly fastidious, or difficult to culture. All species can infect humans. The first three species to be described ; are sometimes referred to as the 'classical species'. Two of these are also motile.

The National Association of State Public Health Veterinarians (NASPHV) develops and publishes uniform public health procedures involving zoonotic disease in the United States and its territories. These veterinarians work closely with emergency rooms, legislators, local officials, schools, health departments, and the general public to prevent disease exposure and control diseases that are transmitted to humans from animals and animal products.

<span class="mw-page-title-main">Kennel cough</span> Upper respiratory infection affecting dogs

Kennel cough is an upper respiratory infection affecting dogs. There are multiple causative agents, the most common being the bacterium Bordetella bronchiseptica, followed by canine parainfluenza virus, and to a lesser extent canine coronavirus. It is highly contagious; however, adult dogs may display immunity to reinfection even under constant exposure. Kennel cough is so named because the infection can spread quickly among dogs in the close quarters of a kennel or animal shelter.

<i>Carnivore protoparvovirus 1</i> Species of parvovirus

Carnivore protoparvovirus 1 is a species of parvovirus that infects carnivorans. It causes a highly contagious disease in both dogs and cats separately. The disease is generally divided into two major genogroups: FPV containing the classical feline panleukopenia virus (FPLV), and CPV-2 containing the canine parvovirus type 2 (CPV-2) which appeared in the 1970s.

<span class="mw-page-title-main">Dog health</span> Health of dogs

The health of dogs is a well studied area in veterinary medicine.

<span class="mw-page-title-main">Canine parvovirus</span> Contagious virus mainly affecting dogs

Canine parvovirus is a contagious virus mainly affecting dogs and wolves. CPV is highly contagious and is spread from dog to dog by direct or indirect contact with their feces. Vaccines can prevent this infection, but mortality can reach 91% in untreated cases. Treatment often involves veterinary hospitalization. Canine parvovirus often infects other mammals including foxes, wolves, cats, and skunks. Felines (cats) are also susceptible to panleukopenia, a different strain of parvovirus.

<span class="mw-page-title-main">Canine influenza</span>

Canine influenza is influenza occurring in canine animals. Canine influenza is caused by varieties of influenzavirus A, such as equine influenza virus H3N8, which was discovered to cause disease in canines in 2004. Because of the lack of previous exposure to this virus, dogs have no natural immunity to it. Therefore, the disease is rapidly transmitted between individual dogs. Canine influenza may be endemic in some regional dog populations of the United States. It is a disease with a high morbidity but a low incidence of death.

<span class="mw-page-title-main">Veterinary dentistry</span> Branch of veterinary medicine

Veterinary dentistry is the field of dentistry applied to the care of animals. It is the art and science of prevention, diagnosis, and treatment of conditions, diseases, and disorders of the oral cavity, the maxillofacial region, and its associated structures as it relates to animals.

A vaccine-associated sarcoma (VAS) or feline injection-site sarcoma (FISS) is a type of malignant tumor found in cats which has been linked to certain vaccines. VAS has become a concern for veterinarians and cat owners alike and has resulted in changes in recommended vaccine protocols. These sarcomas have been most commonly associated with rabies and feline leukemia virus vaccines, but other vaccines and injected medications have also been implicated.

<span class="mw-page-title-main">Cat health</span> Health of domestic cats

The health of domestic cats is a well studied area in veterinary medicine.

<span class="mw-page-title-main">Rabies vaccine</span> Vaccines to prevent rabies in humans and animals

The rabies vaccine is a vaccine used to prevent rabies. There are several rabies vaccines available that are both safe and effective. Vaccinations must be administered prior to rabies virus exposure or within the latent period after exposure to prevent the disease. Transmission of rabies virus to humans typically occurs through a bite or scratch from an infectious animal, but exposure can occur through indirect contact with the saliva from an infectious individual.

Feline vaccination is animal vaccination applied to cats. Vaccination plays a vital role in protecting cats from infectious diseases, some of which are potentially fatal. They can be exposed to these diseases from their environment, other pets, or even humans.

<span class="mw-page-title-main">Rabies</span> Deadly viral disease, transmitted through animals

Rabies is a viral disease that causes encephalitis in humans and other mammals. It was historically referred to as hydrophobia due to the symptom of panic when presented with liquids to drink. Early symptoms can include fever and abnormal sensations at the site of exposure. These symptoms are followed by one or more of the following symptoms: nausea, vomiting, violent movements, uncontrolled excitement, fear of water, an inability to move parts of the body, confusion, and loss of consciousness. Once symptoms appear, the result is virtually always death, regardless of treatment. The time period between contracting the disease and the start of symptoms is usually one to three months but can vary from less than one week to more than one year. The time depends on the distance the virus must travel along peripheral nerves to reach the central nervous system.

Almost all human deaths caused by rabies occur in Asia and Africa.

<span class="mw-page-title-main">Rabies in animals</span> Deadly zoonotic disease

In animals, rabies is a viral zoonotic neuroinvasive disease which causes inflammation in the brain and is usually fatal. Rabies, caused by the rabies virus, primarily infects mammals. In the laboratory it has been found that birds can be infected, as well as cell cultures from birds, reptiles and insects. The brains of animals with rabies deteriorate. As a result, they tend to behave bizarrely and often aggressively, increasing the chances that they will bite another animal or a person and transmit the disease.

A vaccine-preventable disease is an infectious disease for which an effective preventive vaccine exists. If a person acquires a vaccine-preventable disease and dies from it, the death is considered a vaccine-preventable death.

ATCvet code QI07Immunologicals for Canidae is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System for veterinary medicinal products, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products for veterinary use. Subgroup QI07 is part of the anatomical group QI Immunologicals.

DA2PP is a multivalent vaccine for dogs that protects against the viruses indicated by the alphanumeric characters forming the abbreviation: D for canine distemper, A2 for canine adenovirus type 2, which offers cross-protection to canine adenovirus type 1, the first P for canine parvovirus, and the second P for parainfluenza. Because infectious canine hepatitis is another name for canine adenovirus type 1, an H is sometimes used instead of A. In DA2PPC, the C indicates canine coronavirus. This is not considered a core vaccination and is therefore often excluded from the abbreviation.

<span class="mw-page-title-main">Animal vaccination</span> Process

Animal vaccination is the immunisation of a domestic, livestock or wild animal. The practice is connected to veterinary medicine. The first animal vaccine invented was for chicken cholera in 1879 by Louis Pasteur. The production of such vaccines encounter issues in relation to the economic difficulties of individuals, the government and companies. Regulation of animal vaccinations is less compared to the regulations of human vaccinations. Vaccines are categorised into conventional and next generation vaccines. Animal vaccines have been found to be the most cost effective and sustainable methods of controlling infectious veterinary diseases. In 2017, the veterinary vaccine industry was valued at US$7 billion and it is predicted to reach US$9 billion in 2024.

References

  1. 1 2 3 4 5 6 7 8 9 10 Vaccination Guidelines Group (VGG) of the World Small Animal Veterinary Association (WSAVA) (2010). "WSAVA guidelines for the vaccination of dogs and cats" (PDF). Archived (PDF) from the original on 2012-05-26. Retrieved 2012-06-24.
  2. 1 2 3 "2011 AAHA Canine Vaccination Guidelines" (PDF). American Animal Hospital Association (AAHA) Canine Vaccination Task Force. 2011. Archived (PDF) from the original on 2012-05-15. Retrieved 2012-06-23.
  3. 1 2 Moore GE, Guptill LF, Ward MP, Glickman NW, Faunt KK, Lewis HB, Glickman LT (Oct 2005). "Adverse events diagnosed within three days of vaccine administration in dogs". J Am Vet Med Assoc. 227 (7): 1102–8. doi: 10.2460/javma.2005.227.1102 . PMID   16220670.
  4. 1 2 "Canine and Feline Vaccination Guidelines". UC Davis Veterinary Medical Teaching Hospital. November 2009. Archived from the original on 2012-09-05. Retrieved 2012-08-26.
  5. "Feline Life Stage Guidelines" (PDF). American Association of Feline Practicitioners & American Animal Hospital Association. 2010. Archived from the original (PDF) on 2010-07-18. Retrieved 2012-08-26.
  6. Eigner, Diane R. "Feline Vaccine Guidelines". The Winn Feline Foundation. Archived from the original on 2006-08-20. Retrieved 2006-08-27.
  7. "VAFSTF Vaccine Site Recommendations". Vaccine-Associated Feline Sarcoma Task Force of the American Association of Feline Practitioners (AAFP), American Animal Hospital Association (AAHA), American Veterinary Medical Association (AVMA), and Veterinary Cancer Society (VCS). Archived from the original on 2012-05-16. Retrieved 2012-06-23.
  8. "Compendium of Animal Rabies Prevention and Control, 2011". Morbidity and Mortality Weekly Report of the Centers for Disease Control. National Association of State Public Health Veterinarians, Inc. (NASPHV). 2011. Archived from the original on 2017-07-11. Retrieved 2017-09-17.
  9. "Canine and Feline Vaccination Guidelines". UC Davis School of Veterinary Medicine. Archived from the original on 2012-05-06. Retrieved 2012-06-23.
  10. Rhodes, Karen Helton; Werner, Alexander H. (2011-01-25). Blackwell's Five-Minute Veterinary Consult Clinical Companion. Ames, Iowa: Wiley-Blackwell. p. 44. ISBN   978-0-8138-1596-1.